Cue Biopharma (CUE) Non Operating Income (2018 - 2026)
Cue Biopharma (CUE) recorded Non Operating Income of -$65.37 million in Q2 2026, compared with $153,000 a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Non Operating Income (2018 - 2026) Analysis & Trends
On a TTM basis, Cue Biopharma's Non Operating Income came in at -$64.97 million as of Jun 30, 2026; for FY2025, it came in at $450,000, down 45.5% from FY2024.
- Annual Non Operating Income has a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- Across earlier years, Non Operating Income came in at $826,000 in FY2024 (-41.7%), $1.42 million in FY2023 (+558.6%), $215,000 in FY2022 (+368.4%) and $45,898 in FY2021 (-90.1%).
- The Q2 2026 figure is the lowest quarterly Non Operating Income in data going back to Q1 2018.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 444.7% in Q3 2023, against a decline of 95.0% in Q4 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Cue Biopharma | 121.14 Mn | 30.41 Mn | - | -65.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -65.37 Mn |
| Dec 31, 2025 | 107,000.00 |
| Sep 30, 2025 | 147,000.00 |
| Jun 30, 2025 | 153,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 137,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Jun 30, 2024 | 212,000.00 |
| Mar 31, 2024 | 321,000.00 |
| Dec 31, 2023 | 398,000.00 |
| Sep 30, 2023 | 414,000.00 |
| Jun 30, 2023 | 332,000.00 |
| Mar 31, 2023 | 271,000.00 |
| Dec 31, 2022 | 274,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Jun 30, 2022 | -118,000.00 |
| Mar 31, 2022 | -17,000.00 |
| Dec 31, 2021 | 3,898.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 24,000.00 |
API Access
Cue Biopharma Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();